OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID‐19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS‐CoV‐2 infection and care of allergy patients
Oliver Pfaar, Maria J. Torres, Cezmi A. Akdiş
Allergy (2020) Vol. 76, Iss. 3, pp. 622-625
Open Access | Times Cited: 12
Oliver Pfaar, Maria J. Torres, Cezmi A. Akdiş
Allergy (2020) Vol. 76, Iss. 3, pp. 622-625
Open Access | Times Cited: 12
Showing 12 citing articles:
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
COVID‐19 pandemic and allergen immunotherapy—an EAACI survey
Oliver Pfaar, Ioana Agache, Matteo Bonini, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3504-3516
Open Access | Times Cited: 35
Oliver Pfaar, Ioana Agache, Matteo Bonini, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3504-3516
Open Access | Times Cited: 35
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergo
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie select (2021) Vol. 5, Iss. 01, pp. 140-147
Open Access | Times Cited: 33
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie select (2021) Vol. 5, Iss. 01, pp. 140-147
Open Access | Times Cited: 33
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
Montserrat Álvaro‐Lozano, Mónica Sandoval, Mattia Giovannini, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Montserrat Álvaro‐Lozano, Mónica Sandoval, Mattia Giovannini, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection
Francesca Galluzzi, Verónica Rossi, Cristina Bosetti, et al.
Neuroepidemiology (2021) Vol. 55, Iss. 2, pp. 154-161
Closed Access | Times Cited: 22
Francesca Galluzzi, Verónica Rossi, Cristina Bosetti, et al.
Neuroepidemiology (2021) Vol. 55, Iss. 2, pp. 154-161
Closed Access | Times Cited: 22
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
Allergologie select (2021) Vol. 5, Iss. 01, pp. 251-259
Open Access | Times Cited: 10
Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
Allergologie select (2021) Vol. 5, Iss. 01, pp. 251-259
Open Access | Times Cited: 10
Allergic reactions to COVID‐19 vaccinations—unveiling the secret(s)
Oliver Pfaar, Vera Mahler
Allergy (2021) Vol. 76, Iss. 6, pp. 1621-1623
Open Access | Times Cited: 8
Oliver Pfaar, Vera Mahler
Allergy (2021) Vol. 76, Iss. 6, pp. 1621-1623
Open Access | Times Cited: 8
Sulforaphane: from death rate heterogeneity in countries to candidate for prevention of severe COVID-19
Jean Bousquet, Josep Anto, Heather J. Zar, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 8
Jean Bousquet, Josep Anto, Heather J. Zar, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 8
Recent advances and developments in COVID‐19 in the context of allergic diseases
Mei Ding, Xiang Dong, Yuanli Sun, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 7
Mei Ding, Xiang Dong, Yuanli Sun, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 7
Prevalence and Prognostic Factors Associated with Early Recovery of Olfactory Dysfunction in COVID-19 Patients
Pattraporn Kreesaeng, Navarat Tangbumrungtham, Ratchaporn Rachapattayakhom, et al.
Ear Nose & Throat Journal (2023) Vol. 103, Iss. 1_suppl, pp. 68S-75S
Open Access | Times Cited: 1
Pattraporn Kreesaeng, Navarat Tangbumrungtham, Ratchaporn Rachapattayakhom, et al.
Ear Nose & Throat Journal (2023) Vol. 103, Iss. 1_suppl, pp. 68S-75S
Open Access | Times Cited: 1
Die Allergen-Immuntherapie – State of the Art 2020
Oliver Pfaar
Drug Research (2020) Vol. 70, Iss. S 01, pp. S24-S26
Open Access | Times Cited: 1
Oliver Pfaar
Drug Research (2020) Vol. 70, Iss. S 01, pp. S24-S26
Open Access | Times Cited: 1
COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika)
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergo Journal (2021) Vol. 30, Iss. 5, pp. 24-33
Open Access | Times Cited: 1
Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergo Journal (2021) Vol. 30, Iss. 5, pp. 24-33
Open Access | Times Cited: 1
